An exploration of relative health stock in advanced cancer patients. Gaskin, D. J., Weinfurt, K. P., Castel, L. D., DePuy, V., Li, Y., Balshem, A., Benson, A., Burnett, C. B., Corbett, S., Marshall, J., Slater, E., Sulmasy, D. P., Van Echo, D., Meropol, N. J., & Schulman, K. A. Medical decision making : an international journal of the Society for Medical Decision Making, 24:614–624, 2004.
doi  abstract   bibtex   1 download  
The authors sought to empirically test whether relative health stock, a measure of patients' sense of loss in their health due to illness, influences the treatment decisions of patients facing life-threatening conditions. Specifically, they estimated the effect of relative health stock on advanced cancer patients' decisions to participate in phase I clinical trials. A multicenter study was conducted to survey 328 advanced cancer patients who were offered the opportunity to participate in phase I trials. The authors asked patients to estimate the probabilities of therapeutic benefits and toxicity, their relative health stock, risk preference, and the importance of quality of life. Controlling for health-related quality of life, an increase in relative health stock by 10 percentage points reduced the odds of choosing to participate in a phase I trial by 16% (odds ratio = 0.84, 95% confidence interval = 0.72, 0.97). Relative health stock affects advanced cancer patients' treatment decisions.
@Article{Gaskin2004,
  author          = {Gaskin, Darrell J. and Weinfurt, Kevin P. and Castel, Liana D. and DePuy, Venita and Li, Yun and Balshem, Andrew and Benson, Al and Burnett, Caroline B. and Corbett, Sandra and Marshall, John and Slater, Elyse and Sulmasy, Daniel P. and Van Echo, David and Meropol, Neal J. and Schulman, Kevin A.},
  title           = {An exploration of relative health stock in advanced cancer patients.},
  doi             = {10.1177/0272989X04271041},
  issn            = {0272-989X},
  issue           = {6},
  pages           = {614--624},
  pubstate        = {ppublish},
  volume          = {24},
  abstract        = {The authors sought to empirically test whether relative health stock, a measure of patients' sense of loss in their health due to illness, influences the treatment decisions of patients facing life-threatening conditions. Specifically, they estimated the effect of relative health stock on advanced cancer patients' decisions to participate in phase I clinical trials. A multicenter study was conducted to survey 328 advanced cancer patients who were offered the opportunity to participate in phase I trials. The authors asked patients to estimate the probabilities of therapeutic benefits and toxicity, their relative health stock, risk preference, and the importance of quality of life. Controlling for health-related quality of life, an increase in relative health stock by 10 percentage points reduced the odds of choosing to participate in a phase I trial by 16% (odds ratio = 0.84, 95% confidence interval = 0.72, 0.97). Relative health stock affects advanced cancer patients' treatment decisions.},
  citation-subset = {IM},
  completed       = {2005-03-03},
  country         = {United States},
  issn-linking    = {0272-989X},
  journal         = {Medical decision making : an international journal of the Society for Medical Decision Making},
  keywords        = {Clinical Trials, Phase I as Topic; Costs and Cost Analysis; Decision Making; Decision Support Techniques; Female; Health Knowledge, Attitudes, Practice; Health Status; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, pathology, psychology, therapy; Patient Participation, psychology; Quality of Life, psychology; Risk Assessment},
  nlm-id          = {8109073},
  owner           = {NLM},
  pii             = {24/6/614},
  pmid            = {15534342},
  pubmodel        = {Print},
  revised         = {2007-11-15},
  year            = {2004},
}
Downloads: 1